Ross Downing
About Ross Downing
Ross Downing is a professional currently working for the Government of Canada, with a strong background in quality management and compliance within the pharmaceuticals industry. He has held various roles in organizations such as FCT, ExxonMobil, and Janssen Pharmaceutical Companies, demonstrating expertise in regulatory compliance and quality assurance.
Current Role at Government of Canada
Ross Downing has been employed at the Government of Canada since 2019. In this role, he contributes to various initiatives and projects that align with government objectives. His experience in regulatory compliance and quality assurance supports the government's efforts in maintaining standards across different sectors.
Previous Experience in Pharmaceuticals and Quality Assurance
Prior to his current position, Ross Downing worked in the pharmaceuticals industry, notably as a Research Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2003 to 2006. He also served as Head of Quality Department at Canadian Plasma Resources from 2017 to 2019 and as Head of Narcotics Department/QA/QC at Kohl & Frisch Limited from 2013 to 2016. His roles involved managing quality assurance systems and ensuring compliance with regulatory standards.
Education and Academic Background
Ross Downing studied at the University of Moncton, where he focused on Organic Chemistry. He completed his Master's degree between 2003 and 2006. This academic background provided him with a strong foundation in scientific principles, which he has applied throughout his career in various roles.
Skills in Team Management and Training
Ross Downing has demonstrated skills in team management and training, particularly within the context of quality assurance and regulatory compliance. His experience includes leading teams to ensure adherence to industry standards and conducting training sessions to enhance team performance in compliance-related tasks.
Expertise in Regulatory Compliance
Ross Downing possesses specialized knowledge in handling narcotics, controlled drugs, and precursors. He has experience in the cannabis industry and has managed quality assurance systems while conducting inspections and audits for regulatory bodies such as Health Canada, the EU, the FDA, and the German Health Authority.